Company intelligence / Profile preview

Sorrento Therapeutics

San Diego, California, United Statessorrentotherapeutics.com ↗

Ownership: Public · SRNE
Development stage: Commercial

Overview

Sorrento developed a broad pipeline with clinical-stage assets in oncology, pain management, infectious diseases including COVID‑19 therapies and diagnostics. Lead programs included STI‑1558 for COVID‑19 in Phase III trials and several oncology candidates such as STI–6129 for multiple myeloma in Phase I/II. The company filed for bankruptcy in early/mid–2020s and is no longer operating as an independent entity.

Therapeutic areas: OncologyNeurologyInfectious Diseases
Modalities: Antibody-drug conjugateSmall moleculeCell therapyMonoclonal antibodyGene therapyOncolytic virus therapy
Industry: Biotech

Drug pipeline

37 assets

abivertinib

36 more assets in the full pipeline.

Request access →

Partnerships

Notable collaborations with U.S. government agencies such as NIAID/NIH for pandemic diagnostics development ($4.6M contract)plus historical licensing/development deals with other biotechs/pharmas on specific platforms/assets.

Financials

Market cap: $275.6K
Total revenue: $15M
Enterprise value: $127.2M

Beyond the preview

Go deeper on Sorrento Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sorrento Therapeutics.

Explore the full profile